borderline significanceP = 0.059
In the basal‐like model (MAS98.12), a dose–response experiment resulted in reduction of tumor growth compared with control at a dose of 40 mg·kg −1 with borderline significance (Wilcoxon's P = 0.059).
In the basal‐like model (MAS98.12), a dose–response experiment resulted in reduction of tumor growth compared with control at a dose of 40 mg·kg −1 with borderline significance (Wilcoxon's P = 0.059).
However, the difference in protein expression did not reach statistical significance after correction for multiple testing (false discovery rate [FDR]‐adjusted P ‐values).
In our monotherapy experiments, the basal‐like PDX model showed a growth inhibitory response to LXR ligands of borderline significance not apparent in the luminal PDX.